Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Ulrik Nielsen
FOU | Founder | 52 | 01/01/93 |
Gary Crocker
CEO | Chief Executive Officer | 72 | 01/01/04 |
Investor Relations Contact | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Gary Crocker
CEO | Chief Executive Officer | 72 | 01/01/04 |
Director/Board Member | 45 | 19/09/19 | |
Ulrik Nielsen
FOU | Founder | 52 | 01/01/93 |
Director/Board Member | 46 | 19/09/19 | |
Ana Radeljevic
BRD | Director/Board Member | 44 | 06/06/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 14 531 760 | 14 355 601 ( 98,79 %) | 0 | 98,79 % |
Coordinate società
Merrimack Pharmaceuticals, Inc.
One Broadway 14th Floor
02142, Cambridge
+
http://www.merrimackpharma.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+29,03% | 48,16 Mrd | |
-0,10% | 41,73 Mrd | |
+43,45% | 41,03 Mrd | |
-5,26% | 28,77 Mrd | |
+11,48% | 25,59 Mrd | |
-22,74% | 18,96 Mrd | |
+9,06% | 12,92 Mrd | |
+30,01% | 12,03 Mrd | |
-1,51% | 11,77 Mrd |